The findings, published in Cell Genomics, build on other recent work by researchers at Oxford Population Health and the University of Toronto aimed at identifying the earliest signs of cancer development through highly sensitive blood profiling that captures DNA changes.
Cancer remains the second leading cause of death globally, with deaths often resulting from a late diagnosis. When cancers are detected early, treatment is more likely to succeed, and patients have a better chance of surviving.